At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PEAR Pear Therapeutics
Delisted 12-23 07:57:33 EST
0.0292
+0.0000
0.00%
High0.0292
Low0.0292
Vol0.00
Open0.0292
D1 Closing0.0292
Amplitude0.00%
Mkt Cap4.17M
Tradable Cap1.64M
Total Shares142.74M
T/O2.29M
T/O Rate0.00%
Tradable Shares56.11M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Introduction
Company Name.
Pear Therapeutics
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines in the United States. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastroenterology, cardiology, and oncology. Pear Therapeutics, Inc. was incorporated in 2013 and is headquartered in Boston, Massachusetts. On April 7, 2023, Pear Therapeutics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.